Clinically Significant Drug Interactions with New Immunosuppressive Agents

被引：0
|
作者：
Christian Mignat
机构：
[1] Christian Albrechts University of Kiel,Department of Pharmacology
来源：
Drug Safety | 1997年 / 16卷
关键词：
Adis International Limited; Tacrolimus; Sirolimus; Mycophenolate Mofetil; Danazol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tacrolimus (FK506), mycophenolate mofetil, sirolimus (rapamycin), gusperimus, and monoclonal antibody preparations are new immunosuppressive agents, some of which are already approved for clinical use, while others are currently undergoing clinical trials. The present article provides an overview of adverse drug interactions between these immunosuppressants and other drugs which may be used concomitantly.
引用
收藏
页码：267 / 278
页数：11
相关论文
共 50 条
  • [41] Immunosuppressive drug interactions with anti-infective agents
    不详
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 164 - 166
  • [42] Clinically Significant Drug Interactions with Cholinesterase InhibitorsA Guide for Neurologists
    Danièle Bentué-Ferrer
    Olivier Tribut
    Elisabeth Polard
    Hervé Allain
    CNS Drugs, 2003, 17 : 947 - 963
  • [43] Antidepressant-drug interactions are potentially but rarely clinically significant
    DeVane, C. Lindsay
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (08) : 1594 - 1604
  • [44] Clinically Significant Drug Interactions with General AnaestheticsIncidence, Mechanisms and Management
    Mohamed Naguib
    Magboul M. A. Magboul
    Randa Jaroudi
    CNS Drugs, 1997, 8 : 51 - 78
  • [45] ANTIEPILEPTIC DRUGS - A REVIEW OF CLINICALLY SIGNIFICANT DRUG-INTERACTIONS
    PATSALOS, PN
    DUNCAN, JS
    DRUG SAFETY, 1993, 9 (03) : 156 - 184
  • [46] Lack of Clinically Significant Drug Interactions between Nevirapine and Buprenorphine
    McCance-Katz, Elinore F.
    Moody, David E.
    Morse, Gene D.
    Ma, Qing
    Rainey, Petrie M.
    AMERICAN JOURNAL ON ADDICTIONS, 2010, 19 (01): : 30 - 37
  • [47] Clinically relevant drug interactions of current antifungal agents
    Gubbins, Paul O.
    Heldenbrand, Seth
    MYCOSES, 2010, 53 (02) : 95 - 113
  • [48] Clinically significant drug interactions with cholinesterase inhibitors -: A guide for neurologists
    Bentué-Ferrer, D
    Tribut, O
    Polard, E
    Allain, H
    CNS DRUGS, 2003, 17 (13) : 947 - 963
  • [49] Clinically significant pharmacokinetic drug interactions between antiepileptic drugs
    Tanaka, E
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (02) : 87 - 92
  • [50] CIGARETTE-SMOKING AND CLINICALLY SIGNIFICANT DRUG-INTERACTIONS
    SCHEIN, JR
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (11) : 1139 - 1148
12345